ID
27949
Description
Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease
Keywords
Versions (2)
- 10/18/17 10/18/17 -
- 12/6/17 12/6/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
December 6, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
status of treatment blind Ropinirole CR Ropinirole IR Monotherapy 101468/168
status of treatment blind Ropinirole CR Ropinirole IR Monotherapy 101468/168
Description
STATUS OF TREATMENT BLIND
Description
If Yes, complete the following
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0749659
- UMLS CUI [1,2]
- C2347038
Description
Date blind broken
Data type
date
Alias
- UMLS CUI [1,1]
- C3897431
- UMLS CUI [1,2]
- C0011008
Description
Reason blind broken
Data type
text
Alias
- UMLS CUI [1,1]
- C3897431
- UMLS CUI [1,2]
- C0392360
Description
Other reason blind broken
Data type
text
Alias
- UMLS CUI [1,1]
- C3897431
- UMLS CUI [1,2]
- C2347038
- UMLS CUI [1,3]
- C3845569
Similar models
status of treatment blind Ropinirole CR Ropinirole IR Monotherapy 101468/168
C0678257 (UMLS CUI [1,2])
C2347038 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C2347038 (UMLS CUI [1,2])
C3845569 (UMLS CUI [1,3])